Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

(2021) Martine Piccart et al.   LANCET ONCOLOGY

Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy

(2020) Leonora de Boo et al.   EUROPEAN JOURNAL OF CANCER

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

(2020) Zuzana Kos et al.   npj Breast Cancer

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

(2019) Sherene Loi et al.   JOURNAL OF CLINICAL ONCOLOGY

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

(2019) Richard Gray et al.   LANCET

Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

(2019) J H Park et al.   ANNALS OF ONCOLOGY

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

(2018) Ellen R Copson et al.   LANCET ONCOLOGY

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

(2018) Joseph A. Sparano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Breast cancer in adolescents and young adults

(2018) Rebecca H. Johnson et al.   PEDIATRIC BLOOD & CANCER

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study

(2017) Gwen MHE Dackus et al.   BMJ Open

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

(2016) Nadine Tung et al.   JOURNAL OF CLINICAL ONCOLOGY

Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy—Results From a Longitudinal Study

(2016) Sanne Menning et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Effect of BRCA germline mutations on breast cancer prognosis

(2016) Zora Baretta et al.   MEDICINE

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

(2016) Carsten Denkert et al.   MODERN PATHOLOGY

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

(2016) Serena Nik-Zainal et al.   NATURE

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

(2015) Carsten Denkert et al.   JOURNAL OF CLINICAL ONCOLOGY

The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients

(2015) Tomoya Tachi et al.   PLoS One

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

(2014) S. Loi et al.   ANNALS OF ONCOLOGY

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

(2014) R. Salgado et al.   ANNALS OF ONCOLOGY

Survival Outcomes of Metaplastic Breast Cancer Patients: Results from a US Population-based Analysis

(2014) Rebecca A. Nelson et al.   ANNALS OF SURGICAL ONCOLOGY

Comparison of younger and older breast cancer survivors and age-matched controls on specific and overall quality of life domains

(2014) Victoria L. Champion et al.   CANCER

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population

(2014) Alexandra J van den Broek et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

(2014) Sylvia Adams et al.   JOURNAL OF CLINICAL ONCOLOGY

The Table 2 Fallacy: Presenting and Interpreting Confounder and Modifier Coefficients

(2013) D. Westreich et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

(2013) Sherene Loi et al.   JOURNAL OF CLINICAL ONCOLOGY

The prognostic significance of lymphovascular invasion in invasive breast carcinoma

(2011) Emad A. Rakha et al.   CANCER

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment

(2009) J. M. Bueno-de-Mesquita et al.   ANNALS OF ONCOLOGY

Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

(2009) Farrah Kassam et al.   Clinical Breast Cancer

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2009) Monika K. Graeser et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials

(2008)   LANCET